RT Journal Article
SR Electronic
T1 A genome-wide association study of mammographic texture variation
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.07.25.22278024
DO 10.1101/2022.07.25.22278024
A1 Yuxi Liu
A1 Hongjie Chen
A1 John Heine
A1 Sara Lindstroem
A1 Constance Turman
A1 Erica T. Warner
A1 Stacey J. Winham
A1 Celine M. Vachon
A1 Rulla M. Tamimi
A1 Peter Kraft
A1 Xia Jiang
YR 2022
UL http://medrxiv.org/content/early/2022/07/25/2022.07.25.22278024.abstract
AB Background Breast parenchymal texture features, including gray scale variation (V), capture the patterns of texture variation on a mammogram and are associated with breast cancer risk, independent of mammographic density (MD). However, our knowledge on the genetic basis of these texture features is limited.Methods We conducted a genome-wide association study of V in 7,040 European-ancestry women. Four V assessments representing different amounts of breast edge erosion and image resolutions were generated from digitized film mammograms. We used linear regression to test the single-nucleotide polymorphism (SNP)-phenotype associations adjusting for age, body mass index (BMI), MD phenotypes, and the top four genetic principal components. Multivariate phenotype association tests combining all four V assessments were performed. We further calculated genetic correlations and performed SNP-set tests of V with MD, breast cancer risk, and other breast cancer risk factors.Results We identified three genome-wide significant loci associated with V: rs138141444 (6q24.1) in ECT2L, rs79670367 (8q24.22) in LINC01591, and rs113174754 (12q22) near PGAM1P5. 6q24.1 and 8q24.22 have not previously been associated with MD phenotypes or breast cancer risk, whilst 12q22 is a known locus for both MD and breast cancer risk. Among known MD and breast cancer risk SNPs, we identified four variants that were associated with V at the Bonferroni-corrected thresholds accounting for the number of SNPs tested: rs335189 (5q23.2) in PRDM6, rs13256025 (8p21.2) in EBF2, rs11836164 (12p12.1) near SSPN, and rs17817449 (16q12.2) in FTO. We observed significant genetic correlations between V and mammographic dense area (rg = 0.79, P = 5.91 × 10−5), percent density (rg = 0.73, P = 1.00 × 10−4), and adult BMI (rg = -0.36, P = 3.88 × 10−7). Additional significant relationships were observed for nondense area (z = -4.14, P = 3.42 × 10−5), estrogen receptor-positive breast cancer (z = 3.41, P = 6.41 × 10−4), and childhood body fatness (z = -4.91, P = 9.05 × 10−7) from the SNP-set tests.Conclusions These findings provide new insights into the genetic basis of mammographic texture variation and their associations with MD, breast cancer risk, and other breast cancer risk factors.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work is supported by the National Cancer Institute (R01CA175080 and R01CA131332 to R.M.T., R01CA244670 to S.L., and R03CA224196 to X.J.), Avon Foundation for Women, Susan G. Komen for the Cure, and Breast Cancer Research Foundation. The Nurses' Health Study is supported by the National Cancer Institute (UM1CA186107, P01CA87969, and R01CA49449). The Nurses' Health Study II is supported by the National Cancer Institute (U01CA176726 and R01CA67262). The Mayo Mammography Health Study is supported by the National Cancer Institute (R01CA128931 and R01CA97396).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of the Brigham and Women's Hospital, Harvard T.H. Chan School of Public Health, and the Mayo Clinic gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNHS/NHSII: The data that support the findings of this study are available from the Nurses' Health Studies, however they are not publicly available. Investigators interested in using the data can request access, and feasibility will be discussed at an investigators' meeting. Limits are not placed on scientific questions or methods, and there is no requirement for co-authorship. Additional data sharing information and policy details can be accessed at http://www.nurseshealthstudy.org/researchers. MMHS: The summary statistics generated from the current study are available from the corresponding author on reasonable request.BCACBreast Cancer Association ConsortiumBMIbody mass indexDAdense areaERestrogen receptorGWASgenome-wide association studyLDlinkage disequilibriumMDmammographic densityMMHSMayo Mammography Health StudyNDAnondense areaNHSNurses’ Health StudyPCprincipal componentPDpercent densitySNPsingle-nucleotide polymorphismVIFvariance inflation factorV75HV with 25% erosion and high resolutionV75LV with 25% erosion and low resolutionV65HV with 35% erosion and high resolutionV65LV with 35% erosion and low resolution